Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (14071) 14071
Publication (1096) 1096
Book Review (89) 89
Book / eBook (51) 51
Book Chapter (48) 48
Newspaper Article (23) 23
Conference Proceeding (21) 21
Dissertation (16) 16
Newsletter (9) 9
Government Document (3) 3
Reference (3) 3
Magazine Article (2) 2
Report (2) 2
Web Resource (2) 2
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (11151) 11151
male (7460) 7460
radiopharmaceuticals (7091) 7091
female (7003) 7003
index medicus (6064) 6064
middle aged (5164) 5164
radiology, nuclear medicine & medical imaging (4880) 4880
adult (4026) 4026
aged (3990) 3990
animals (3667) 3667
radiopharmaceuticals - pharmacokinetics (3177) 3177
radionuclide imaging (2618) 2618
radiopharmaceuticals - administration & dosage (2381) 2381
fluorodeoxyglucose f18 (2377) 2377
oncology (2267) 2267
positron-emission tomography (2197) 2197
medicine & public health (2059) 2059
positron-emission tomography - methods (2039) 2039
positron-emission-tomography (1952) 1952
sensitivity and specificity (1896) 1896
nuclear medicine (1866) 1866
tissue distribution (1793) 1793
pet (1643) 1643
cancer (1625) 1625
imaging / radiology (1560) 1560
positron emission tomography (1507) 1507
aged, 80 and over (1488) 1488
mice (1474) 1474
treatment outcome (1467) 1467
reproducibility of results (1448) 1448
pet imaging (1345) 1345
radiopharmaceuticals - therapeutic use (1345) 1345
rats (1198) 1198
tomography, x-ray computed (1189) 1189
cardiology (1096) 1096
tomography, emission-computed, single-photon (1078) 1078
retrospective studies (1069) 1069
brain - diagnostic imaging (1004) 1004
tomography (990) 990
diagnosis (961) 961
tumors (918) 918
magnetic resonance imaging (913) 913
prognosis (888) 888
surgery (879) 879
radiotherapy (874) 874
adolescent (825) 825
predictive value of tests (822) 822
radiology (811) 811
therapy (787) 787
care and treatment (777) 777
prospective studies (774) 774
medical imaging (762) 762
time factors (744) 744
pharmacology & pharmacy (743) 743
tomography, emission-computed, single-photon - methods (742) 742
cardiac & cardiovascular systems (734) 734
orthopedics (721) 721
radiopharmaceuticals - chemistry (720) 720
brain - metabolism (718) 718
neurosciences (674) 674
radiopharmaceuticals - chemical synthesis (673) 673
neoplasm staging (669) 669
fdg-pet (661) 661
article (658) 658
spect (653) 653
medicine (649) 649
fluorodeoxyglucose f18 - pharmacokinetics (641) 641
brain (639) 639
in-vivo (633) 633
chemotherapy (625) 625
tomography, x-ray computed - methods (625) 625
carcinoma (617) 617
tomography, emission-computed (614) 614
follow-up studies (610) 610
child (584) 584
radiopharmaceuticals - adverse effects (583) 583
young adult (576) 576
analysis (564) 564
cell line, tumor (564) 564
metabolic clearance rate (545) 545
research (534) 534
technetium tc 99m sestamibi (515) 515
patients (495) 495
radioisotopes (484) 484
metastasis (479) 479
scintigraphy (467) 467
rats, sprague-dawley (466) 466
usage (463) 463
diagnostic radiology (453) 453
organotechnetium compounds (453) 453
metabolism (448) 448
breast cancer (442) 442
health aspects (441) 441
breast neoplasms - diagnostic imaging (440) 440
neoplasms - diagnostic imaging (434) 434
diagnosis, differential (432) 432
radiopharmaceuticals - metabolism (429) 429
technetium (427) 427
risk factors (424) 424
radiation dosage (423) 423
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (32) 32
Online Resources - Online (4) 4
Collection Dvlpm't (Acquisitions) - Closed Orders (3) 3
Collection Dvlpm't (Acquisitions) - Vendor file (3) 3
UofT at Mississauga - Stacks (2) 2
St. Michael's Hospital - Stacks (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
Toronto East General Hospital - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (13802) 13802
Spanish (113) 113
French (110) 110
German (97) 97
Japanese (86) 86
Russian (32) 32
Chinese (19) 19
Czech (14) 14
Portuguese (12) 12
Italian (11) 11
Hungarian (9) 9
Polish (9) 9
Korean (3) 3
Lithuanian (3) 3
Serbian (3) 3
Swedish (2) 2
Danish (1) 1
Finnish (1) 1
Greek (1) 1
Indonesian (1) 1
Romanian (1) 1
Slovak (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text US intergroup trial of response-adapted therapy for stage III to IV Hodgkin lymphoma using early interim fluorodeoxyglucose-positron emission tomography imaging: Southwest Oncology Group S0816
by Press, Oliver W and Li, Hongli and Schöder, Heiko and Straus, David J and Moskowitz, Craig H and LeBlanc, Michael and Rimsza, Lisa M and Bartlett, Nancy L and Evens, Andrew M and Mittra, Erik S and LaCasce, Ann S and Sweetenham, John W and Barr, Paul M and Fanale, Michelle A and Knopp, Michael V and Noy, Ariela and Hsi, Eric D and Cook, James R and Lechowicz, Mary Jo and Gascoyne, Randy D and Leonard, John P and Kahl, Brad S and Cheson, Bruce D and Fisher, Richard I and Friedberg, Jonathan W
Journal of Clinical Oncology, ISSN 0732-183X, 06/2016, Volume 34, Issue 17, pp. 2020 - 2027
Purpose Four US National Clinical Trials Network components (Southwest Oncology Group, Cancer and Leukemia Group B/Alliance, Eastern Cooperative Oncology... 
FDG-PET | SURVIVAL | ABVD | ONCOLOGY | CLINICAL-TRIALS | BEACOPP | DISEASE | INTENSITY | RADIOTHERAPY | INTERNATIONAL PROGNOSTIC SCORE | CHEMOTHERAPY | Hodgkin Disease - diagnostic imaging | Procarbazine - administration & dosage | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Hodgkin Disease - pathology | Humans | Middle Aged | Vinblastine - administration & dosage | Young Adult | Hodgkin Disease - drug therapy | Vincristine - administration & dosage | Adult | Radiopharmaceuticals | Doxorubicin - administration & dosage | Dacarbazine - administration & dosage | Prednisone - administration & dosage | Etoposide - administration & dosage | Bleomycin - administration & dosage | Positron-Emission Tomography - methods | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Fluorodeoxyglucose F18 | Neoplasm Staging | Granulocyte Colony-Stimulating Factor - administration & dosage | Index Medicus | Dxst3 | Timg2 | Bios3 | Hema13 | ORIGINAL REPORTS | Hema11
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Administration of imaging pharmaceuticals
by Tortorici, Marianne R
1996, ISBN 9780721648132, xv, 158
Diagnostic Imaging | Contrast Media | Diagnosis, Radioisotope | Radiopharmacueticals | methods
Book
Details down arrow
3. Full Text Effects of isoflurane anesthesia and intravenous morphine self‐administration on regional glucose metabolism ([18F]FDG‐PET) of male Sprague‐Dawley rats
by Park, Thomas Y and Nishida, Kevin S and Wilson, Colin M and Jaiswal, Shalini and Scott, Jessica and Hoy, Andrew R and Selwyn, Reed G and Dardzinski, Bernard J and Choi, Kwang H and Barrot, Michel
European Journal of Neuroscience, ISSN 0953-816X, 04/2017, Volume 45, Issue 7, pp. 922 - 931
Although certain drugs of abuse are known to disrupt brain glucose metabolism (BGluM), the effects of opiates on BGluM are not well characterized. Moreover,... 
brain imaging | brain energy metabolism | opiate addition | drug self‐administration | drug self-administration | 2-DEOXYGLUCOSE | SMALL ANIMAL PET | NALOXONE | NEUROSCIENCES | ADDICTION | DEPENDENCE | POSITRON-EMISSION-TOMOGRAPHY | NUCLEUS | RECEPTORS | WITHDRAWAL | BRAIN | Anesthetics, Inhalation - pharmacology | Fluorodeoxyglucose F18 - pharmacokinetics | Radiopharmaceuticals - pharmacokinetics | Anesthetics, Inhalation - administration & dosage | Isoflurane - pharmacology | Morphine - pharmacology | Substance Withdrawal Syndrome - etiology | Anesthesia, Intravenous - adverse effects | Analgesics, Opioid - pharmacology | Rats | Isoflurane - adverse effects | Male | Anesthetics, Inhalation - adverse effects | Corpus Striatum - metabolism | Rats, Sprague-Dawley | Positron Emission Tomography Computed Tomography | Analgesics, Opioid - adverse effects | Animals | Analgesics, Opioid - administration & dosage | Corpus Striatum - drug effects | Corpus Striatum - diagnostic imaging | Morphine - administration & dosage | Morphine - adverse effects | Glucose metabolism | Brain research | PET imaging | Physiological aspects | Anesthesia | Morphine | Glucose | Dextrose | Cerebellum | Brain | Cortex (olfactory) | Drug abuse | Basal ganglia | Intravenous administration | Mesencephalon | Emission analysis | Stimulation | Opiates | Hypothalamus | Infusion | Computed tomography | Rodents | Neostriatum | Thalamus | Defecation | Jugular vein | Self-administration | Narcotics | Therapeutic applications | Positron emission | Injection | Metabolism | Isoflurane | Ganglia | Emissions control | Positron emission tomography | Hippocampus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text High Occupancy of Sigma-1 Receptors in the Human Brain after Single Oral Administration of Fluvoxamine: A Positron Emission Tomography Study Using [11 C]SA4503
by Ishikawa, Masatomo and Ishiwata, Kiichi and Ishii, Kenji and Kimura, Yuichi and Sakata, Muneyuki and Naganawa, Mika and Oda, Keiichi and Miyatake, Ryousuke and Fujisaki, Mihisa and Shimizu, Eiji and Shirayama, Yukihiko and Iyo, Masaomi and Hashimoto, Kenji
Biological Psychiatry, ISSN 0006-3223, 2007, Volume 62, Issue 8, pp. 878 - 883
Background Sigma-1 receptors might be implicated in the pathophysiology of psychiatric diseases, as well as in the mechanisms of action of some selective... 
Psychiatry | SSRI | sigma-1 receptor | paroxetine | occupancy | Fluvoxamine | PET | DELUSIONAL DEPRESSION | NEGATIVE SYMPTOMS | PSYCHIATRY | AFFECTIVE-DISORDERS | SCHIZOPHRENIA | fluvoxamine | NEUROSCIENCES | CNS SIGMA RECEPTORS | SEROTONIN REUPTAKE INHIBITORS | ANTIDEPRESSANTS | LIGANDS | PSYCHOTIC DEPRESSION | BINDING-PROPERTIES | Serotonin Uptake Inhibitors - metabolism | Brain - diagnostic imaging | Fluvoxamine - metabolism | Humans | Male | Piperazines - metabolism | Positron-Emission Tomography | Receptors, sigma - genetics | Paroxetine - metabolism | Brain - metabolism | Dose-Response Relationship, Drug | Paroxetine - administration & dosage | Radiopharmaceuticals - metabolism | Fluvoxamine - administration & dosage | Serotonin Uptake Inhibitors - administration & dosage | Adult | Polymorphism, Single Nucleotide | Receptors, sigma - metabolism | PET imaging | Serotonin uptake inhibitors | Radioactive tracers
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Successful administration of ipilimumab to two kidney transplantation patients with metastatic melanoma
by Lipson, Evan J and Bodell, Mabel A and Kraus, Edward S and Sharfman, William H
Journal of Clinical Oncology, ISSN 0732-183X, 07/2014, Volume 32, Issue 19, pp. e69 - e71
ONCOLOGY | RECIPIENTS | SOLID-ORGAN TRANSPLANT | Lymphatic Metastasis - diagnosis | Lung Neoplasms - drug therapy | Melanoma - diagnosis | Lymph Nodes - pathology | Skin Neoplasms - drug therapy | Humans | Ipilimumab | Middle Aged | Fluorodeoxyglucose F18 - metabolism | Antibodies, Monoclonal - therapeutic use | Male | Tomography, X-Ray Computed | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Radiopharmaceuticals - metabolism | Lung Neoplasms - secondary | Skin Neoplasms - diagnosis | Dacarbazine - analogs & derivatives | Mycophenolic Acid - administration & dosage | Immunosuppressive Agents - administration & dosage | Tacrolimus - administration & dosage | Skin Neoplasms - pathology | Dacarbazine - administration & dosage | Prednisone - administration & dosage | Drug Administration Schedule | Administration, Oral | Treatment Outcome | Kidney Transplantation | Positron-Emission Tomography - methods | Melanoma - secondary | Mycophenolic Acid - analogs & derivatives | Antibodies, Monoclonal - administration & dosage | Melanoma - drug therapy | Aged | Platinum Compounds - administration & dosage | Lung Neoplasms - diagnosis | To6 | Mela5 | Mela6 | Mela7 | Diagnosis in Oncology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text A human [11C]T-773 PET study of PDE10A binding after oral administration of TAK-063, a PDE10A inhibitor
by Takano, Akihiro and Stenkrona, Per and Stepanov, Vladimir and Amini, Nahid and Martinsson, Stefan and Tsai, Max and Goldsmith, Paul and Xie, Jinhui and Wu, Jingtao and Uz, Tolga and Halldin, Christer and Macek, Thomas A
NeuroImage, ISSN 1053-8119, 11/2016, Volume 141, pp. 10 - 17
Phosphodiesterase 10A (PDE10A) is selectively expressed in the striatal regions in the brain and may play a role in modulating dopaminergic and glutamatergic... 
Reproducibility of Results | Tissue Distribution - drug effects | Phosphoric Diester Hydrolases - metabolism | Radiopharmaceuticals - pharmacokinetics | Administration, Oral | Humans | Middle Aged | Phosphoric Diester Hydrolases - drug effects | Male | Molecular Imaging - methods | Positron-Emission Tomography - methods | Brain - drug effects | Brain - metabolism | Dose-Response Relationship, Drug | Phosphodiesterase Inhibitors - administration & dosage | Pyrazoles - administration & dosage | Sensitivity and Specificity | Pyridazines - administration & dosage | Protein Binding | Adult | Pyridazines - pharmacokinetics | Metabolic Clearance Rate - drug effects | Drug Monitoring | Pyrazoles - pharmacokinetics | Pets | Nervous system diseases | Analysis | Cerebellum | Dopamine | Intravenous administration | Disease | Mental disorders | Oral administration | Schizophrenia | Putamen | Studies | Brain research | Neostriatum | Tomography | Glutamatergic transmission | Pharmaceutical industry | Positron emission tomography | Drug dosages | Dopamine receptors | Phosphodiesterase
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Positron emission tomography has a high negative predictive value for progression or early relapse for patients with residual disease after first-line chemotherapy in advanced-stage Hodgkin lymphoma
by Kobe, C and Dietlein, M and Franklin, J and Markova, J and Lohri, A and Amthauer, H and Klutmann, S and Knapp, W.H and Zijlstra-Baalbergen, J.M and Bockisch, A and Weckesser, M and Lorenz, R and Schreckenberger, M and Bares, R and Eich, H.T and Mueller, R.P and Fuchs, M and Borchmann, P and Schicha, H and Diehl, V and Engert, A
Blood, ISSN 0006-4971, 2008, Volume 112, Issue 10, pp. 3989 - 3994
In the HD15 trial of the German Hodgkin Study Group, the negative predictive value (NPV) of positron emission tomography (PET) using [F-18]-fluorodeoxyglucose... 
FDG-PET | TRIALS | THERAPY | METAANALYSIS | FREE SURVIVAL | CYCLES | EARLY INTERIM | REGIMEN | RADIOTHERAPY | HEMATOLOGY | STANDARD | Fluorodeoxyglucose F18 - administration & dosage | Hodgkin Disease - diagnostic imaging | Procarbazine - administration & dosage | Predictive Value of Tests | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Middle Aged | Male | Neoplasm, Residual | Hodgkin Disease - drug therapy | Hodgkin Disease - mortality | Vincristine - administration & dosage | Adult | Doxorubicin - administration & dosage | Prednisone - administration & dosage | Risk Factors | Etoposide - administration & dosage | Survival Rate | Bleomycin - administration & dosage | Positron-Emission Tomography - methods | Radiography | Radiopharmaceuticals - administration & dosage | Disease-Free Survival | Adolescent | Index Medicus | Abridged Index Medicus | Clinical Trials and Observations
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text [18F]fluorodeoxyglucose positron emission tomography predicts survival after chemoimmunotherapy for primary mediastinal large B-cell lymphoma: Results of the International Extranodal Lymphoma Study Group IELSG-26 study
by Martelli, Maurizio and Ceriani, Luca and Zucca, Emanuele and Zinzani, Pier Luigi and Ferreri, Andrés J. M and Vitolo, Umberto and Stelitano, Caterina and Brusamolino, Ercole and Cabras, Maria Giuseppina and Rigacci, Luigi and Balzarotti, Monica and Salvi, Flavia and Montoto, Silvia and Lopez-Guillermo, Armando and Finolezzi, Erica and Pileri, Stefano A and Davies, Andrew and Cavalli, Franco and Giovanella, Luca and Johnson, Peter W. M
Journal of Clinical Oncology, ISSN 0732-183X, 06/2014, Volume 32, Issue 17, pp. 1769 - 1775
Purpose To assess the role of [F-18] fluorodeoxyglucose ([F-18] FDG) positron emission tomography/computed tomography (PET/CT) after rituximab and... 
NON-HODGKINS-LYMPHOMA | ONCOLOGY | PET | CHEMOTHERAPY
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Imaging robust microglial activation after lipopolysaccharide administration in humans with PET
by Christine M. Sandiego and Jean-Dominique Gallezot and Brian Pittman and Nabeel Nabulsi and Keunpoong Lim and Shu-Fei Lin and David Matuskey and Jae-Yun Lee and Kevin C. O’Connor and Yiyun Huang and Richard E. Carson and Jonas Hannestad and Kelly P. Cosgrove
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 10/2015, Volume 112, Issue 40, pp. 12468 - 12473
Neuroinflammation is associated with a broad spectrum of neurodegenerative and psychiatric diseases. The core process in neuroinflammation is activation of... 
PBR28 | Neuroinflammation | Cytokines | Endotoxin | Microglia | MULTIDISCIPLINARY SCIENCES | SYSTEMIC INFLAMMATION | POSITRON-EMISSION-TOMOGRAPHY | PROTEIN 18 KDA | TRANSLOCATOR PROTEIN | MULTIPLE-SCLEROSIS | neuroinflammation | PERIPHERAL BENZODIAZEPINE-RECEPTOR | IN-VIVO | cytokines | microglia | VIVO RADIOLIGAND BINDING | endotoxin | COGNITIVE DEFICITS | Microglia - metabolism | Humans | Lipopolysaccharides - administration & dosage | Pyridines - pharmacokinetics | Male | Lipopolysaccharides - immunology | Brain - metabolism | Young Adult | Radiopharmaceuticals - metabolism | Microglia - immunology | Inflammation Mediators - metabolism | Adult | Cytokines - blood | Biomarkers - metabolism | Reproducibility of Results | Radiopharmaceuticals - pharmacokinetics | Acetamides - pharmacokinetics | Cytokines - metabolism | Carbon Radioisotopes - pharmacokinetics | Inflammation Mediators - blood | Positron-Emission Tomography - methods | Acetamides - metabolism | Pyridines - metabolism | Receptors, GABA - metabolism | Protein Binding | Carbon Radioisotopes - metabolism | Brain - immunology | Physiological aspects | Inflammation | Health aspects | Lipopolysaccharides | Biological Sciences
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Thoracic positron emission tomography using 18F-fluorodeoxyglucose for the evaluation of residual mediastinal Hodgkin disease
by Weihrauch, Martin R and Re, Daniel and Scheidhauer, Klemens and Ansén, Sascha and Dietlein, Markus and Bischoff, Stefanie and Bohlen, Heribert and Wolf, Jürgen and Schicha, Harald and Diehl, Volker and Tesch, Hans
Blood, ISSN 0006-4971, 11/2001, Volume 98, Issue 10, pp. 2930 - 2934
Residual mediastinal masses are frequently observed in patients with Hodgkin disease (HD) after completed therapy, and the discrimination between active tumor... 
Hodgkin Disease - diagnostic imaging | Procarbazine - administration & dosage | Predictive Value of Tests | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prospective Studies | Follow-Up Studies | Hodgkin Disease - pathology | Humans | Salvage Therapy | Transplantation, Autologous | Life Tables | Vinblastine - administration & dosage | False Positive Reactions | Mediastinal Neoplasms - therapy | Hodgkin Disease - mortality | Vincristine - administration & dosage | Radiopharmaceuticals | Radiotherapy, Adjuvant | Doxorubicin - administration & dosage | Dacarbazine - administration & dosage | Diagnosis, Differential | Prednisone - administration & dosage | Dexamethasone - administration & dosage | False Negative Reactions | Hematopoietic Stem Cell Transplantation | Etoposide - administration & dosage | Combined Modality Therapy | Neoplasm Recurrence, Local - diagnosis | Bleomycin - administration & dosage | Mediastinal Neoplasms - diagnostic imaging | Remission Induction | Cytarabine - administration & dosage | Disease-Free Survival | Melphalan - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Mediastinal Neoplasms - pathology | Hodgkin Disease - therapy | Fibrosis | Fluorodeoxyglucose F18 | Tomography, Emission-Computed | Carmustine - administration & dosage
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Bifunctional coupling agents for radiolabeling of biomolecules and target-specific delivery of metallic radionuclides
by Liu, Shuang
Advanced Drug Delivery Reviews, ISSN 0169-409X, 2008, Volume 60, Issue 12, pp. 1347 - 1370
Receptor-based radiopharmaceuticals are of great current interest in molecular imaging and radiotherapy of cancers, and provide a unique tool for... 
Radionuclides | Diagnosis | Radiopharmaceuticals | Target-specific delivery | Radiotherapy | Organotechnetium Compounds - chemistry | Radiopharmaceuticals - chemistry | Gallium Radioisotopes - administration & dosage | Humans | Indium Radioisotopes - chemistry | Gallium Radioisotopes - chemistry | Organotechnetium Compounds - administration & dosage | Yttrium Radioisotopes - administration & dosage | Drug Delivery Systems | Radiopharmaceuticals - administration & dosage | Animals | Indium Radioisotopes - administration & dosage | Isotope Labeling | Radioisotopes - administration & dosage | Copper Radioisotopes - administration & dosage | Copper Radioisotopes - chemistry | Radioisotopes - chemistry | Yttrium Radioisotopes - chemistry | Biochemistry | radiotherapy | radiopharmaceuticals | diagnosis | target-specific delivery | radionuclides
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Radium Ra 223 dichloride injection: U.S. food and drug administration drug approval summary
by Kluetz, Paul G and Pierce, William and Maher, V. Ellen and Zhang, Hui and Tang, Shenghui and Song, Pengfei and Liu, Qi and Haber, Martin T and Leutzinger, Eldon E and Al-Hakim, Ali and Chen, Wei and Palmby, Todd and Alebachew, Elleni and Sridhara, Rajeshwari and Ibrahim, Amna and Justice, Robert and Pazdur, Richard
Clinical Cancer Research, ISSN 1078-0432, 01/2014, Volume 20, Issue 1, pp. 9 - 14
On May 15, 2013, the U. S. Food and Drug Administration (FDA) approved radium Ra 223 dichloride (Ra-223; Xofigo injection; Bayer HealthCare Pharmaceuticals... 
TRIAL | PREDNISONE | MITOXANTRONE | ONCOLOGY | INCREASED SURVIVAL | DOCETAXEL | METASTATIC PROSTATE-CANCER | CHEMOTHERAPY | ABIRATERONE | Bone Neoplasms - mortality | Radioisotopes - therapeutic use | Double-Blind Method | Prostatic Neoplasms, Castration-Resistant - radiotherapy | United States | Humans | Radioisotopes - adverse effects | Kaplan-Meier Estimate | Bone Neoplasms - secondary | Male | Treatment Outcome | Drug Approval | Radium - adverse effects | Radium - therapeutic use | Prostatic Neoplasms, Castration-Resistant - pathology | Bone Neoplasms - radiotherapy | Animals | Aged | Prostatic Neoplasms, Castration-Resistant - mortality | Radiopharmaceuticals - adverse effects | Radiopharmaceuticals - therapeutic use | United States Food and Drug Administration
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights